180 related articles for article (PubMed ID: 1568585)
1. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
[TBL] [Abstract][Full Text] [Related]
2. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.
Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Uribe M
Ren Fail; 1995 Jan; 17(1):13-20. PubMed ID: 7770639
[TBL] [Abstract][Full Text] [Related]
3. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Poo JL; Feldmann G; Moreau A; Gaudin C; Lebrec D
J Hepatol; 1993 Aug; 19(1):90-4. PubMed ID: 8301049
[TBL] [Abstract][Full Text] [Related]
4. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
[TBL] [Abstract][Full Text] [Related]
7. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
He H; Mennone A; Boyer JL; Cai SY
Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
Azer SA; Canfield PJ; Stacey NH
J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
[TBL] [Abstract][Full Text] [Related]
9. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.
Bosch J; Enriquez R; Groszmann RJ; Storer EH
Hepatology; 1983; 3(6):1002-7. PubMed ID: 6629314
[TBL] [Abstract][Full Text] [Related]
10. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
Abdel Kawy HS
Eur J Pharmacol; 2015 Apr; 752():8-17. PubMed ID: 25666386
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid alleviates cholestasis-induced histophysiological alterations in the male reproductive system of bile duct-ligated rats.
Saad RA; Mahmoud YI
Reprod Toxicol; 2014 Dec; 50():87-97. PubMed ID: 25461907
[TBL] [Abstract][Full Text] [Related]
14. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats.
Jalink D; Urbanski SJ; Lee SS
J Hepatol; 1996 Dec; 25(6):924-31. PubMed ID: 9007722
[TBL] [Abstract][Full Text] [Related]
15. Effects of ursodeoxycholic acid on splanchnic and systemic hemodynamics. A double-blind, cross-over, placebo-controlled study in healthy volunteers.
Schiedermaier P; Hansen S; Asdonk D; Brensing K; Sauerbruch T
Digestion; 2000; 61(2):107-12. PubMed ID: 10705174
[TBL] [Abstract][Full Text] [Related]
16. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
[TBL] [Abstract][Full Text] [Related]
17. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
Oberti F; Rifflet H; Maïga MY; Pilette C; Gallois Y; Douay O; Le Jeune JJ; Saumet JL; Calès P
J Hepatol; 1997 Jan; 26(1):167-73. PubMed ID: 9148008
[TBL] [Abstract][Full Text] [Related]
18. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
19. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
Chazouillères O; Marteau P; Haniche M; Jian R; Poupon R
Dig Dis Sci; 1996 Dec; 41(12):2417-22. PubMed ID: 9011452
[TBL] [Abstract][Full Text] [Related]
20. The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.
Sokolovic D; Nikolic J; Kocic G; Jevtovic-Stoimenov T; Veljkovic A; Stojanovic M; Stanojkovic Z; Sokolovic DM; Jelic M
Drug Chem Toxicol; 2013 Apr; 36(2):141-8. PubMed ID: 22385135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
